5//SEC Filing
Marshall William Stuart 5
Accession 0001209191-20-009420
CIK 0001590750other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 6:58 PM ET
Size
6.8 KB
Accession
0001209191-20-009420
Insider Transaction Report
Form 5
Marshall William Stuart
DirectorPresident & CEO
Transactions
- Award
Common Stock
2019-02-21$2.46/sh+1,250$3,071→ 269,396 total - Award
Common Stock
2019-08-21$1.14/sh+1,250$1,424→ 270,646 total
Footnotes (1)
- [F1]These shares were acquired under the Miragen Therapeutics, Inc. 2016 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
MIRAGEN THERAPEUTICS, INC.
CIK 0001590750
Entity typeother
Related Parties
1- filerCIK 0001693127
Filing Metadata
- Form type
- 5
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 6:58 PM ET
- Size
- 6.8 KB